Patents by Inventor Hartmut Kupper

Hartmut Kupper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USES AND COMPOSITIONS FOR TREATMENT OF ANKLOSING SPONDYLITIS
    Publication number: 20190040124
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Application
    Filed: February 28, 2018
    Publication date: February 7, 2019
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Desiree Van Der Heijde, Walter P. Maksymowych
  • USES AND COMPOSITIONS FOR TREATMENT OF RHEUMATOID ARTHRITIS
    Publication number: 20170157249
    Abstract: The invention provides methods, uses and compositions for the treatment of rheumatoid arthritis. The invention describes methods and uses for treating rheumatoid arthritis wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of rheumatoid arthritis in a subject.
    Type: Application
    Filed: July 21, 2016
    Publication date: June 8, 2017
    Inventors: Hartmut Kupper, Jeffrey D. Kent, Mary A. Cifaldi, John L. Perez
  • Uses and Compositions for Treatment of Ankylosing Spondylitis
    Publication number: 20160251424
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Application
    Filed: March 7, 2016
    Publication date: September 1, 2016
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Desiree Van Der Heijde, Walter P. Maksymowych
  • Methods for determining efficacy of TNF-? inhibitors for treatment of rheumatoid arthritis
    Patent number: 9399061
    Abstract: The invention provides methods, uses and compositions for the treatment of rheumatoid arthritis. The invention describes methods and uses for treating rheumatoid arthritis wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of rheumatoid arthritis in a subject.
    Type: Grant
    Filed: April 10, 2007
    Date of Patent: July 26, 2016
    Assignee: ABBVIE BIOTECHNOLOGY LTD
    Inventors: Hartmut Kupper, Jeffrey D. Kent, Mary A. Cifaldi, John L. Perez, Gerd R. Burmester, Philip Mease, Daniel J. Lovell, Edward Keystone, Arthur Kavanaugh
  • Methods for treatment of ankylosing spondylitis using TNF alpha antibodies
    Patent number: 9279015
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Grant
    Filed: February 4, 2008
    Date of Patent: March 8, 2016
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Walter P. Maksymowych
  • Uses and Compositions for Treatment of Rheumatoid Arthritis
    Publication number: 20150064194
    Abstract: The invention provides methods, uses and compositions for the treatment of rheumatoid arthritis. The invention describes methods and uses for treating rheumatoid arthritis wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of rheumatoid arthritis in a subject.
    Type: Application
    Filed: October 28, 2014
    Publication date: March 5, 2015
    Inventors: Hartmut Kupper, Jeffrey D. Kent, Mary A. Cifaldi, John L. Perez
  • USES AND COMPOSITIONS FOR TREATMENT OF RHEUMATOID ARTHRITIS
    Publication number: 20150064195
    Abstract: The invention provides methods, uses and compositions for the treatment of rheumatoid arthritis. The invention describes methods and uses for treating rheumatoid arthritis wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of rheumatoid arthritis in a subject.
    Type: Application
    Filed: October 28, 2014
    Publication date: March 5, 2015
    Inventors: HARTMUT KUPPER, JEFFREY D. KENT, MARY A. CIFALDI, JOHN L. PEREZ
  • Uses and Compositions for Treatment of Rheumatoid Arthritis
    Publication number: 20150056212
    Abstract: The invention provides methods, uses and compositions for the treatment of rheumatoid arthritis. The invention describes methods and uses for treating rheumatoid arthritis wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of rheumatoid arthritis in a subject.
    Type: Application
    Filed: October 28, 2014
    Publication date: February 26, 2015
    Inventors: Hartmut Kupper, Jeffrey D. Kent, Mary A. Cifaldi, John L. Perez
  • Method of treating ankylosing spondylitis
    Patent number: 8926975
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Grant
    Filed: June 17, 2014
    Date of Patent: January 6, 2015
    Assignee: AbbVie Biotechnology Ltd
    Inventors: Robert L. Wong, Hartmut Kupper, John R. Medich
  • USES AND COMPOSITIONS FOR TREATMENT OF RHEUMATOID ARTHRITIS
    Publication number: 20120171123
    Abstract: The invention provides methods, uses and compositions for the treatment of rheumatoid arthritis. The invention describes methods and uses for treating rheumatoid arthritis wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of rheumatoid arthritis in a subject.
    Type: Application
    Filed: October 25, 2011
    Publication date: July 5, 2012
    Inventors: John R. Medich, Hartmut Kupper, John L. Perez, Jeffrey D. Kent, Eric H. Sasso, Oscar Segurado, George Spencer-Green, Theodore Pincus
  • METHODS AND COMPOSITIONS FOR PREDICTING RESPONSIVENESS TO TREATMENT WITH TNF-ALPHA INHIBITOR
    Publication number: 20120014956
    Abstract: The invention provides methods of determining or predicting the responsiveness of a subject to treatment with a TNF? inhibitor, such as a TNF? antibody by determining genetic factors.
    Type: Application
    Filed: February 2, 2011
    Publication date: January 19, 2012
    Inventors: Hartmut Kupper, Hendrik Schulze-Koops, Alla Skapenko
  • Uses and compositions for treatment of ankylosing spondylitis
    Publication number: 20090123378
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Application
    Filed: February 4, 2008
    Publication date: May 14, 2009
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Desiree Van Der Heijde, Walter P. Maksymowych
  • Uses and compositions for treatment of rheumatoid arthritis
    Publication number: 20080166348
    Abstract: The invention provides methods, uses and compositions for the treatment of rheumatoid arthritis. The invention describes methods and uses for treating rheumatoid arthritis wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of rheumatoid arthritis in a subject.
    Type: Application
    Filed: April 10, 2007
    Publication date: July 10, 2008
    Inventors: Hartmut Kupper, Jeffrey D. Kent, Mary A. Cifaldi, John L. Perez, Gerd R. Burmester, Philip Mease, Daniel J. Lovell, Edward Keystone, Arthur Kavanaugh
  • Uses and compositions for treatment of rheumatoid arthritis
    Publication number: 20080131374
    Abstract: The invention provides methods, uses and compositions for the treatment of rheumatoid arthritis. The invention describes methods and uses for treating rheumatoid arthritis wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of rheumatoid arthritis in a subject.
    Type: Application
    Filed: May 4, 2007
    Publication date: June 5, 2008
    Inventors: John R. Medich, Hartmut Kupper, Jeffrey D. Kent, John L. Perez, Eric H. Sasso, Oscar Segurado, George Spencer-Green, Theodore Pincus